Scripta Therapeutics

Scripta Therapeutics

Private
OxfordHealthcare & Life Scienceshttps://scriptatherapeutics.com

Last Round

Seed

Nov 13, 2025

Total Funding Raised

$12M

Momentum Score

25 /100

Company Overview

Scripta Therapeutics is a techbio company that has developed a platform using AI, advanced imaging, and patient-derived models to discover drugs by modulating transcription factor activity, with an initial focus on neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discovery platformAI drug discoverytranscription factor modulationtranscription factorsneurodegenerationTechBiodisease-modifying therapeuticsmulti-omicscomputational drug discoveryin silico drug discoverypatient-derived modelsprecision medicinegene regulationpharmaceutical partnershipsbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scripta Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scripta Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 13, 2025

Key People

Founding team and executive leadership

Peter Hamley

Founder And CEO

Founding Team

Scripta Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2025

    $12M raised in Seed round.

  • Nov 13, 2025

    Ray Barlow appointed as Non-Executive Director.

Scripta Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scripta Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scripta Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range21
Year Founded2024
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.